Matsumoto, Masanori http://orcid.org/0000-0002-7243-3126
Miyakawa, Yoshitaka
Kokame, Koichi
Ueda, Yasunori
Wada, Hideo
Higasa, Satoshi
Yagi, Hideo
Ogawa, Yoshiyuki
Sakai, Kazuya
Miyata, Toshiyuki
Morishita, Eriko
Fujimura, Yoshihiro
,
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (20FC1024)
Article History
Received: 6 June 2023
Revised: 21 August 2023
Accepted: 23 August 2023
First Online: 10 September 2023
Declarations
:
: Masanori Matsumoto received consultant/advisor fees from Sanofi, Takeda Pharmaceutical, Alexion Pharma, and Chugai Pharmaceutical; patent royalties from Alfresa Pharma; research funds from Sanofi and Alexion Pharma; lecture fees from Sanofi, Takeda Pharmaceutical, and Alexion Pharma; and scholarship donations from Chugai Pharmaceutical and Asahi Kasei Pharma. Yoshitaka Miyakawa received medical consultant fees from Zenyaku Kogyo Argenx SE, research funds from Chugai Pharma, Alexion Pharma, Sanofi, Pfizer, Novo Nordisk and Janssen, and lecture fees from Chugai Pharmaceutical, Alexion Pharma, and Sanofi. Koichi Kokame received patent royalties from Kainos, Peptide Institute, and Werfen. Yasunori Ueda received consultant/advisor fees from Sanofi and Otsuka Pharmaceutical, and lecture fees from Sanofi and Japan Blood Products Organization. Hideo Wada declares no conflicts of interest associated with this manuscript. Satoshi Higasa received lecture fees from Sanofi, Takeda Pharmaceutical, CSL Behring, Novo Nordisk Pharma, and Chugai Pharmaceutical; and scholarship donations from Chugai Pharmaceutical. Hideo Yagi declares no conflicts of interest associated with this manuscript. Yoshiyuki Ogawa received lecture fees from Chugai Pharmaceutical and scholarship donations from Bayer Yakuhin. Kazuya Sakai received research funds from Takeda Pharmaceutical and lecture fees from Sanofi. Toshiyuki Miyata received patent royalties from Kainos, Peptide Institute, and Werfen. Eriko Morishita received lecture fees from Sanofi. Yoshihiro Fujimura received consultant/special researcher fees from Japanese Red Cross Society Kinki Block Blood Center, advisor fees from Kainos and Sysmex, patent royalties from Alfresa Pharma, and lecture fees from Alexion Pharma.